GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of gene injection aims to halt blinding eye disease
Disease control TerminatedThis early-stage study tested a new gene therapy called GT005 for people with an advanced form of dry age-related macular degeneration (AMD) that causes vision loss. The therapy involved a single injection into the back of the eye, aiming to deliver a gene that might help control…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Eye disease drug trial aims to halt vision loss
Disease control TerminatedThis study tested whether a drug called danicopan could slow the progression of geographic atrophy, a form of age-related macular degeneration that destroys central vision. About 365 participants with the condition took either the drug at different doses or a placebo for up to tw…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC